Abstract

BackgroundThe opioid pandemic, and particularly injection drug use, has led to an increase in cases of tricuspid valve infective endocarditis. Indications for valve surgery in right-sided IE are not well-defined. Percutaneous mechanical aspiration is considered an alternative in patients high-risk for re-infection of a prosthetic valve but lacks robust outcomes data.This retrospective analysis compares the primary outcome of death within one-year for patients with isolated tricuspid valve infective endocarditis treated with medical therapy versus percutaneous mechanical aspiration and valve surgery. MethodsThe authors performed a retrospective cohort study of patients with isolated tricuspid valve infective endocarditis over a 10-year period. Medical record review was performed to collect demographic and outcomes related data. The association between treatment group and outcomes was assessed using Cox proportional hazard regression with inverse probability of treatment weighting. ResultsBetween January 1st, 2009 and December 31st, 2018 215 patients with isolated tricuspid valve infective endocarditis and surgical indications were identified. One-hundred patients (46.5%) were managed medically, 49 (22.8%) were managed surgically, and 66 (30.7%) underwent percutaneous mechanical aspiration. There was no significant difference in 1-year mortality between the three treatment groups (p = 0.15). Vegetation size >2.0 cm was associated with increased 1-year mortality (HR 3.01; p = 0.03). Addiction medicine consultation was associated with decreased 1-year mortality (HR 0.117; p = 0.0008). ConclusionThe study highlights that surgery or percutaneous mechanical aspiration in addition to medical therapy does not improve 1-year mortality in patients with isolated TVIE. Addiction medicine consultation was associated with decreased 1-year mortality in patients with injection drug use-associated isolated tricuspid valve infective endocarditis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call